ically separate. Lesion 1 was a melanoma and lesion 2 was a melanoma arising centrally from a nevus. Both lesions harbored GNAQ mutations. This patient had no family history of uveal melanomas or signs of ocular melanocytosis and was negative for the BAP1 mutation. This case demonstrates how multifocal uveal melanomas can arise in patients who lack genetic predisposition for the disease. Furthermore, this case is one of the few that have shown, histopathologically, a small focus of malignant cells developing from a benign population within a nevus, which highlights the importance of closely monitoring nevi for signs of malignancy.
Introduction
Multifocal uveal melanomas are extremely rare [1] [2] [3] [4] [5] . Evidence suggests that uveal melanoma can either arise de novo [6] or from preexisting nevi [7] . The purpose of this report is to describe a patient with two independent uveal melanomas in the same eye, with one arising from a nevus.
Case Report
A 52-year-old woman with no prior ocular or medical history presented with complaints of decreased peripheral vision in her left eye. Family history was negative for cancer and the right eye was unremarkable. Best-corrected visual acuity was 20/20 OD and 20/150 OS and intraocular pressure was 14 mm Hg OD and 16 mm Hg OS. There were no signs of episcleral melanocytosis. Fundoscopic exam revealed no choroidal melanocytosis, confirmed with transillumination. A large pigmented mushroom-shaped choroidal melanoma was seen (lesion 1) overhanging the optic nerve nasally and occupying most of the nasal hemisphere ( Fig. 1 ). This lesion measured 10.6 mm in diameter and 11.2 mm in thickness. B-scan ultrasonography using the 10-MHz transducer showed cystic cavities, surrounding subretinal fluid, intravascular pulsations, and no extrascleral extension (Fig. 2) . Further ocular examination revealed a 9 × 1.7 mm ciliary choroidal mass superiorly, which was clinically thought to represent a nevus (lesion 2). Ultrasonic biomicroscopy of lesion 2 showed a 1.7-mm lesion extending from the ciliary body and pars plana into the choroid with medium reflectivity and no subretinal fluid, intrinsic vascular pulsations, or extraocular extension. The AJCC classification of tumor 1 was T3a and tumor 2 was T1b.
The patient underwent enucleation (Fig. 2 ) and the specimen was sent for histopathological and immunohistochemical analysis. The enucleated specimen confirmed 2 primary lesions by serial sections in the equatorial plane (Fig. 3) . We were unable to visualize the base of the larger lesion due to fresh tissue harvesting at the time of the enucleation. Lesion 1 was a uveal melanoma, predominantly mixed cell type with rupture of Bruch's membrane and formation of cavitations within the herniated component. Lesion 2 was a choroidal nevus with a focus of melanoma, predominantly spindle cell type with pronounced vasculogenic mimicry, arising within the lateral portion of the lesion. Both tumors expressed G protein alpha-subunit (GNAQ) c.626A>T (Q209L) mutations. BAP1 mutation was negative. Gene expression profiling using Castle Biosciences classified the main tumor (lesion 1) as type IA. The patient has been followed for 16 months and is currently alive with no evidence of metastatic disease on imaging.
Discussion
Multifocal uveal melanomas have been associated with BRCA-associated protein 1 (BAP 1) mutations [8] , familial cancer syndromes [9] , and ocular melanocytosis [10] [11] [12] . While there have been over 20 reports of multiple melanomas in the same eye [1, 2, 4, 5, 13] , this case is unique given the identification of 2 distinct melanomas GNAQ mutations are commonly seen in both nevi and melanomas [14] . This mutation is hypothesized to occur early in tumorigenesis and activate the RAF/MEK/ ERK pathway [15] . On the other hand, BAP1, SF3B1, or EIF1AX mutations are thought to trigger downstream molecular events during tumor progression and some are associated with poorer prognosis than others [16] . We found GNAQ mutations in both lesions, this raises suspicion that there may have been a field of genetically predisposed cells that gave rise to these 2 lesions as seen in ocular melanocytosis despite the fact that there was no clinical evidence. Furthermore, the tumors did not harbor the BAP1 mutation, making a germline predisposition less likely. And she remains without further evidence of disease.
This case demonstrates that multiple choroidal melanomas can arise in one eye even in patients without ocular melanocytosis or genetic predisposition. Furthermore, lesions that clinically appear as nevi may harbor small nests of malignant cells, highlighting the importance of close follow-up. Further cytogenetic studies of these types of tumors may help us gain a better understanding of the pathogenesis of choroidal nevi and melanomas.
